Recent Analyst Forecasts and Stock Ratings
Y-mAbs Therapeutics, Inc. FAQ's
Y-mAbs Therapeutics, Inc. has been rated by research analysts at Morgan Stanley, Canaccord Genuity, Truist Financial, Cantor Fitzgerald, Wedbush, BMO Capital in the past 90 days.